Skip to main content
. 2020 Jan 1;10(2):567–584. doi: 10.7150/thno.36777

Figure 4.

Figure 4

In vivo quantification of 177Lu-labelled nanostar 11 (p([177Lu]Lu-DPAEA-co-OEGA-co-[Gd3+]VDMD)). (A) Uptake study scheme of 177Lu-labelled nanostars in BALB/c mice, isografted with CT26 colon cancer cells. (B) Biodistribution profile of 177Lu-labelled nanostars (~0.8 MBq, MA = ~5 GBq/µmol) up to 3 days after injection in BALB/c mice isografted with CT26 colon cancer cells. Highest tumour accumulation was observed after 3 days, as well as accumulation in liver and spleen. S.I.: small intestine, L.I.: large intestine.